Multiple studies demonstrate the safety of propofol in pediatric EDPS. Each has identified a drop in blood pressure and transient hypoxemia as the most frequent complications. In all of the studies in which hypotension was identified there was no evidence of poor perfusion. The hypoxemia in all of these studies quickly responded to minimal intervention with no apparent lasting complications. Although these were pediatric studies, the results were very similar to ours in complication rates and sedation times. Our study did not demonstrate the frequency of decreased blood pressure seen in these pediatric studies but had similar hypoxemia rates.